Permanent Artificial Skin Market Size, Share & Industry Analysis, By Replacement Area (Epidermal Skin, Dermal Skin), By Material (Natural, Synthetic), By Application (Acute wounds, Chronic wounds, Others), By End-user (Hospitals, Burn Care Centres, Others) And Regional Forecast, 2024-2032

Permanent artificial skin is a skin substitute used to treat burns and wound closure to replace the layer of the skin. It is commonly used in burn victims with deep or partial wounds as it helps in wound coverage and infection prevention. Growing awareness of various skin treatments procedures and rising incidence of acute and chronic wounds augment market growth. For instance, according to WHO, approximately 1,80,000 deaths are caused by burns every year. The majority of burns occurred in low and middle-income countries.

The rising incidence of acute and chronic wounds is estimated to drive the permanent artificial skin market over the forecast duration. For instance, as per the EC endocrinology and metabolic research article, the wound healing society based on etiology classified chronic wounds into four categories: venous ulcers, pressure ulcers, diabetic ulcers, and arterial insufficiency ulcers. According to NCBI, In September 2020, the incidence of diabetic foot ulcers universally is between 9.1 to 26.1 million and thus accelerating the growth of the permanent artificial skin market.

However, the higher price associated with skin treatment is estimated to restrain the market growth during the projected timeframe. As per NCBI, the Medicare cost estimated for acute and chronic wound treatments ranged from USD 28.1 billion to USD 96.8 billion. Moreover, the market growth could also be negatively impacted by stringent regulatory norms.

Key Market Driver -

Rising Incidence of Acute and Chronic wounds to Boost Market Growth

Key Market Restraint -

Higher Cost Associated with the Treatment and Lack of Reimbursements

Market Segmentation:

Globally, the permanent artificial skin market can be segmented into replacement areas, by material, by application, end-user, and region. Based on the replacement area, the market has been divided into epidermal skin and dermal skin. Based on the material, the market can be segmented into natural and synthetic. On the basis of application, the market is segmented into acute wounds, chronic wounds, and others.  Based on end-user segmentation, the market can be categorized into hospitals, burn care centers and others.

Geographically, the permanent artificial skin market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

Key Players Covered:

Some of the major companies that are present in the Permanent Artificial Skin market are Convatec Group Plc, 3M Company, Smith and Nephew, Molnlycke Health Care AB, Integra Lifesciences Corporation, Medtronic, Solsys Medical LLC, Johnson and Johnson Services, and other prominent players

Key Insights:

• Technological Advancements in Permanent Artificial Skin Market


• Key Industry Developments – Merger, Acquisitions, and Partnerships


• Overview of Regulatory Scenario – Key Country/Region


• COVID-19 Impact on Permanent Artificial Skin Market

Regional Analysis:

Based on the segmentation of region, the permanent artificial skin market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is projected to dominate the market in 2021 and is estimated to retain its leading position over the forecast duration. Factors such as technological advancement in the products and the rise in the number of road accidents that required significant medical attention, including skin treatments, fuel the market growth in North America. The European region and APAC region are estimated to secure the second and third leading position in the market, respectively, owing to the factors such as a large number of cases related to wound injuries and rising R&D efforts to develop new products by key players.  For instance, Smith & Nephew, a U.K.-based company, has a product portfolio that comprises skin substitutes. The company’s products are used for treating acute and chronic wounds produced by pressure ulcers and diabetic foot ulcers, post-operative wounds, etc. The company’s artificial skin substitutes include PELNAC, a permanent skin substitute used to repair and replace the damaged dermal layer. These factors combined with others are estimated to reinforce the market growth in Europe and APAC regions for the forthcoming years. The market in Latin America and Middle East and Africa are expected to grow at a slower rate than other regions owed to limited penetration of advanced technology.

To gain extensive insights into the market, Request for Customization

Segmentation

Permanent Artificial Skin Market Industry Developments 

• In October, 2019, 3M made the announcement of the completion of acquisition of Acelity, Inc. and its KCI subsidiaries worldwide. KCI product portfolio include advanced wound dressings and negative pressure surgical solutions. Company’ solutions contribute to raised patient outcomes by enhancing wound healing.


• In June 2019, Misonix, Inc., a provider of minimally invasive therapeutic ultrasonic medical devices announced the completion of acquisition of Solsys Medical. Solsys leading cellular and tissue-based wound treatment, TheraSkin, is highly complementary to Misonix’s cutting-edge ultrasonic wound debridement solution, which will help in advanced wound care channel-to-market and therefore will help company to expand its sales.